For the treatment of peripheral artery disease in leg arteries above the knee, the IN.PACT Admiral drug-coated balloon from Medtronic Inc. provided a consistently favorable treatment effect in patients with diabetes in a landmark study of the investigational medical device, which is under review for FDA approval.
Merit Medical Systems Inc. settled a dispute regarding the distribution of the SecureLoc Safety Introducer Needle with Bard Access Systems. Under the terms of a settlement agreement, Bard Access Systems granted Merit a non-exclusive, worldwide license to manufacture and distribute the SecureLoc Safety Introducer Needle under its own trademark.
Lantheus Medical Imaging Inc. and Shine Medical Technologies Inc. announced that the companies have entered into a strategic agreement for the future supply of molybdenum-99 (Mo-99). The supply agreement marks Lantheus’ first with a prospective United States supplier of Mo-99.
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
Solid Water HE is the next generation of solid water phantoms by Gammex. It is designed for both therapy and imaging with improved uniformity and durability in mind.
Sorin Group, a global medical device company and a leader in the treatment of cardiovascular diseases, implanted the Solo Smart surgical replacement performed by David Heimansohn, M.D., at St. Vincent’s Heart Hospital in Indianapolis, Ind.
Backus Hospital, Hartford Hospital, The Hospital of Central Connecticut, MidState Medical Center, and Windham Hospital now gather and analyze dose data from all necessary modalities within their imaging departments to ensure an effective dose management program for their patients through the use of Sectra DoseTrack.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
This multi-center pilot study focused on gathering data supporting the safety and performance of the Tack Endovascular System in 35 subjects with Critical Limb Ischemia (CLI) due to vascular disease below the knee.
Cardinal Health announced that its MynxGrip Vascular Closure Device recently received U.S. Food and Drug Administration (FDA) approval for use to close femoral veins. The MynxGrip device is now indicated for use to seal 5F, 6F and 7F femoral arterial and femoral venous access sites.
Cardiovascular Systems Inc. received the CE Mark for its Stealth 360º Orbital Atherectomy System (OAS). Stealth 360º is a percutaneous OAS that is indicated to treat patients who suffer from peripheral arterial disease (PAD).
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Calgary Scientific Inc. has announced a partnership with OnBase by Hyland to extend mobile image-access capability to its enterprise content management (ECM) platform. OnBase empowers superior care across the healthcare enterprise by making information readily available to clinicians and staff within the applications they already use and know, driving improvements in patient care and service while reducing operational costs.
The Gammex “micro” diode laser family offers an economical alternative to conventional laser systems used for alignment purposes. Gammex “micro” has dimensions that are considerably smaller than other fixed lasers.
"Innovative fetal intervention may prove to be a game-changer in many cases, but it is too soon to declare its superiority over current conventional strategies for management of hypoplastic left heart syndrome," says Jack Rychik, M.D., director of the Fetal Heart Program at The Children's Hospital of Philadelphia (CHOP).
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
Future prevention and treatment strategies for vascular diseases may lie in the evaluation of early brain imaging tests long before heart attacks or strokes occur, according to a systematic review conducted by a team of cardiologists, neuroscientists, and psychiatrists from Icahn School of Medicine at Mount Sinai and published in the October issue of JACC Cardiovascular Imaging.
The Radiological Society of North America (RSNA) will officially kick off its 100th annual meeting and scientific assembly (Nov. 30 – Dec. 5, McCormick Place, Chicago) with a look back on the role RSNA has played in the history of radiology, brought to life in the RSNA Centennial Showcase.
Enrollment is open for the Dual Epicardial and Endocardial Procedure (DEEP) clinical trial following U.S Food and Drug Administration Approval (FDA).